CORRECTION article

Front. Bioeng. Biotechnol., 10 October 2022

Sec. Industrial Biotechnology

Volume 10 - 2022 | https://doi.org/10.3389/fbioe.2022.1048797

Corrigendum: Large-scale preparation of highly stable recombinant human acidic fibroblast growth factor in Escherichia coli BL21(DE3) plysS strain

  • 1. Wenzhou Medical University, Chashan University Park, Wenzhou, China

  • 2. College of Pharmacy, Chonnam National University, Gwangju, South Korea

  • 3. Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou, China

  • 4. Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju, South Korea

Article metrics

View details

1,3k

Views

665

Downloads

In the published article, an author name was incorrectly written as Bingjieu Yu. The correct spelling is “Bingjie Yu”.

Furthermore, there was an error regarding the affiliation for Bingjie Yu. Beyond having affiliation 1, they should also have affiliation 2 (added here), “College of Pharmacy, Chonnam National University, Gwangju, South Korea.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

rhaFGF135, Escherichia coli BL21(DE3)pLysS, fermentation, purification, wound healing

Citation

Yu B, Sun W, Huang Z, Sun G, Li L, Gu J, Zheng M, Li X, Chun C, Hui Q and Wang X (2022) Corrigendum: Large-scale preparation of highly stable recombinant human acidic fibroblast growth factor in Escherichia coli BL21(DE3) plysS strain. Front. Bioeng. Biotechnol. 10:1048797. doi: 10.3389/fbioe.2022.1048797

Received

20 September 2022

Accepted

22 September 2022

Published

10 October 2022

Approved by

Frontiers Editorial Office

Volume

10 - 2022

Updates

Copyright

*Correspondence: Xiaojie Wang, ; Qi Hui,

†These authors have contributed equally to this work

This article was submitted to Industrial Biotechnology, a section of the journal Frontiers in Bioengineering and Biotechnology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics